AXGN · 10-Q · 2026Q1 · Full report

Strategic Initiatives and Targeting

Axogen, Inc. · 2026-04-28 · Importance 34 · Surprise 42

The company’s stated strategy is to deepen presence in high‑potential accounts, specifically Level 1 trauma centers and academic‑affiliated hospitals with many trained microsurgeons, to drive adoption of its nerve repair solutions. Management intends to grow these accounts via targeted expansion of nerve repair indications and deeper adoption of its nerve repair algorithm across multiple surgical specialties. Proceeds from the January 2026 offering are earmarked for working capital, capital expenditures and general corporate purposes that support this sales and clinical strategy. The company ties this commercial focus to near‑term operational priorities to increase penetration in specialized surgical centers.

Key facts

• The company’s strategy focuses on deepening presence in Level 1 trauma centers and academic-affiliated hospitals with a high number of trained microsurgeons